Dario Palmieri
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
136
Citations
3,718
Est. group size
~23
Recurring co-author estimate
Active years
36
Publishing since 1991
Dario Palmieri's publication record centers on molecular biology and cancer research, particularly the role of small regulatory RNAs called microRNAs, RNA-binding proteins like nucleolin, and gene regulators such as HMGA proteins in cancer development and treatment response. Work spans laboratory studies on breast cancer chemotherapy sensitization, computational (in silico) modeling of RNA-protein interactions, and involvement in clinical and imaging-related studies, suggesting a mix of basic molecular research and translational/clinical collaboration. Note that the publication list also includes unrelated medical physics papers, which may reflect a shared author name or broad collaborative co-authorships rather than a distinct separate research focus.
Publication output peaked around 2018 and has gradually declined and stabilized to a lower but steady rate of about 4-5 papers per year in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- PS05.01 3D PRINTED SENTINEL LYMPH NODE PHANTOM
Physica Medica · 2024
- DOSE EVALUATION FOR 177LU-PRRT RADIATION SAFETY IN PAEDIATRIC PATIENTS
Physica Medica · 2023
- GFR DETERMINATION FROM PLASMA CLEARANCE CURVE: A SIMPLIFIED PROCEDURE USING BLOOD SAMPLES AND HAEMATOCRIT
Physica Medica · 2023
- Speckle-tracking global longitudinal strain as a predictor of clinical outcomes in patients with idiopathic inflammatory myopathies
European Heart Journal · 2023
- In silico study predicts a key role of <scp>RNA</scp> ‐binding domains 3 and 4 in <scp>nucleolin–miRNA</scp> interactions
Proteins Structure Function and Bioinformatics · 2022
- <i>In silico</i> study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactions
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- In silico study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactions.
2021
- Editorial: From “Junk DNA” to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAs
Frontiers in Oncology · 2019
- Safety and Antitumor Activity of Sitravatinib in Combination with Tislelizumab in Patients With Advanced Solid Tumors: Ovarian Cancer Cohort Data
Annals of Oncology · 2019
- Retraction: HMGA Proteins Up-regulate <i>CCNB2</i> Gene in Mouse and Human Pituitary Adenomas
Cancer Research · 2018
- PO-344 miR-302b as adjuvant therapeutic tool to improve chemotherapy efficacy in human triple negative breast cancer
ESMO Open · 2018
- Abstract 5437: miR-302b as adjuvant therapeutic tool to improve chemotherapy efficacy in human triple-negative breast cancer
Cancer Research · 2017
- POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with the human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.
Journal of Biological Chemistry · 2017
- Erratum: Regulation of microRNA expression by HMGA1 proteins
Oncogene · 2016
- MiR-302b improves chemotherapy efficacy in human breast cancer and affects tumor microenvironment
European Journal of Cancer · 2016
- Cancer Research×13
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Research Square×4
- Physica Medica×3
- International Journal of Molecular Sciences×2
- You Li
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jia Shen
Biochemistry, Genetics and Molecular Biology · Indiana University
- Anna Tessari
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Xiao Wang
Biochemistry, Genetics and Molecular Biology · Indiana University
- Kotaro Nakanishi
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile